SCL Science Inc. (KOSDAQ:A246960) agreed to acquire SCL Healthcare Co., Ltd. for approximately KRW 10 billion on December 30, 2024. The exchange ratio is 58.744283:1.

The expected completion of the transaction is March 31, 2025.

SCL Science Inc. (KOSDAQ:A246960) completed the acquisition of SCL Healthcare Co., Ltd. on March 31, 2025. As of the stock exchange date (March 31, 2025), the shares of SCL Healthcare Co., Ltd. owned by the shareholders listed in the shareholders' register of SCL Healthcare Co., Ltd., which is scheduled to become a wholly owned subsidiary, will be transferred to SCL Science Co., Ltd. on the stock exchange date, and 1,195,974 shares will be issued at the rate of 58.7442831 common shares of SCL Science Co., Ltd. for every 1 common stock of SCL Healthcare Co., Ltd.